AspirinPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalTiclopidineThromboxane B2Drug Therapy, CombinationCyclooxygenase InhibitorsPlatelet AggregationSalicylatesPlatelet Function TestsTreatment OutcomeDrug Administration ScheduleBlood PlateletsSodium SalicylateDose-Response Relationship, DrugFibrinolytic AgentsHemorrhageAnticoagulantsAsthma, Aspirin-InducedWarfarinDouble-Blind MethodTablets, Enteric-CoatedCyclooxygenase 1Gastrointestinal HemorrhageBleeding TimePlatelet ActivationTime FactorsProstaglandin-Endoperoxide SynthasesThromboxanesIbuprofenProspective StudiesThromboxane A2ThrombosisRisk FactorsCyclooxygenase 2 InhibitorsDipyridamoleDrug ResistanceAntineoplastic Combined Chemotherapy ProtocolsAcetaminophenFollow-Up StudiesLipoxinsMyocardial InfarctionIndomethacinRecurrenceAdministration, OralGastric MucosaSulfinpyrazoneStrokeCyclooxygenase 2Drug InteractionsStomach UlcerReye SyndromeProstaglandinsRandomized Controlled Trials as TopicNaproxenDrug Hypersensitivity